| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |